Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Health Catalyst (HCAT) Return on Equity (2019 - 2025)

Historic Return on Equity for Health Catalyst (HCAT) over the last 7 years, with Q3 2025 value amounting to 0.32%.

  • Health Catalyst's Return on Equity fell 900.0% to 0.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.32%, marking a year-over-year decrease of 900.0%. This contributed to the annual value of 0.19% for FY2024, which is 1100.0% up from last year.
  • Health Catalyst's Return on Equity amounted to 0.32% in Q3 2025, which was down 900.0% from 0.28% recorded in Q2 2025.
  • Health Catalyst's Return on Equity's 5-year high stood at 0.19% during Q4 2024, with a 5-year trough of 0.49% in Q2 2021.
  • Over the past 5 years, Health Catalyst's median Return on Equity value was 0.32% (recorded in 2023), while the average stood at 0.31%.
  • Its Return on Equity has fluctuated over the past 5 years, first crashed by -1500bps in 2021, then surged by 1900bps in 2022.
  • Health Catalyst's Return on Equity (Quarter) stood at 0.29% in 2021, then decreased by -11bps to 0.32% in 2022, then rose by 1bps to 0.32% in 2023, then skyrocketed by 39bps to 0.19% in 2024, then crashed by -64bps to 0.32% in 2025.
  • Its last three reported values are 0.32% in Q3 2025, 0.28% for Q2 2025, and 0.2% during Q1 2025.